Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy
Lei Zhu, Hongbin Han, Gang Liu, Haichun Zhao, Mengxin Luo · 2026
Read Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy by Lei Zhu, Hongbin Han, Gang Liu, Haichun Zhao, Mengxin Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13596866.txt.
Description
Lei Zhu leads a team on surgery choices in borderline pancreatic cancer. Their review from twenty twenty-six deals with neoadjuvant therapy first. Such therapy is now central to care for these cases.
A structured search gathered trials, cohorts, and guidelines. Pre treatment staging and post therapy selection are covered. Vessel tactics during surgery get their own focus. Care after surgery is part of the synthesis. Anatomy still defines who counts as borderline. Biology and patient state now weigh in more. Surgery is saved for chosen responders. Response checks lean on scans and blood marks.
Catalog record
| CREATOR | Lei Zhu, Hongbin Han, Gang Liu, Haichun Zhao, Mengxin Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |